{"log_id": 5031414280036315479, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 0.021044, "average": 0.929843, "min": 0.431232}, "location": {"width": 708, "top": 376, "height": 63, "left": 408}, "words": "儿童用药:尚木对小于18岁的者进行非布司他的药代动力学研究"}, {"probability": {"variance": 0.015364, "average": 0.938059, "min": 0.472227}, "location": {"width": 895, "top": 418, "height": 68, "left": 408}, "words": "老年人用药;与年轻受试者相比(18-40岁),老年受试者(65岁及以上多次口服"}, {"probability": {"variance": 0.041935, "average": 0.849208, "min": 0.353484}, "location": {"width": 938, "top": 456, "height": 70, "left": 360}, "words": "布他后,非市司及其代谢物的Cn和AUC相似。血尿酸下降率不老与年轻"}, {"probability": {"variance": 0.028037, "average": 0.889669, "min": 0.414511}, "location": {"width": 502, "top": 495, "height": 54, "left": 358}, "words": "的受试者中也基木一致。老年者无整剂量"}, {"probability": {"variance": 0.02309, "average": 0.876403, "min": 0.436025}, "location": {"width": 893, "top": 539, "height": 70, "left": 402}, "words": "肾功能不全者:在轻度(肌酯清除丰50~80 mirin).中(清论30~49"}, {"probability": {"variance": 0.025723, "average": 0.879025, "min": 0.377197}, "location": {"width": 879, "top": 580, "height": 70, "left": 408}, "words": "n)重度(肌消除车10~29 mlain)的肾功能不全的健康受试者中,多次服用80m"}, {"probability": {"variance": 0.029447, "average": 0.900544, "min": 0.457531}, "location": {"width": 941, "top": 616, "height": 75, "left": 351}, "words": "的非布可他,与肾功能正常受试者肌酐清除大于80mI/min)相比,Cm亚,AUC"}, {"probability": {"variance": 0.031266, "average": 0.886831, "min": 0.393919}, "location": {"width": 941, "top": 657, "height": 73, "left": 351}, "words": "与半衰期增加,但肾功能不全的3组中,结果相似。肾功不全者平均丰司AUC值是"}, {"probability": {"variance": 0.039675, "average": 0.843987, "min": 0.378707}, "location": {"width": 932, "top": 699, "height": 70, "left": 358}, "words": "王常的1.8倍,3和活性代订物的平均Cax和AC分别增加到2倍和4倍。但是,功"}, {"probability": {"variance": 0.011245, "average": 0.940907, "min": 0.543829}, "location": {"width": 863, "top": 740, "height": 68, "left": 349}, "words": "能不全者的血清尿酸下降平与正常者类似〔正常者是58%,重度肾功能不全是55"}, {"probability": {"variance": 0.025591, "average": 0.893511, "min": 0.441406}, "location": {"width": 874, "top": 781, "height": 70, "left": 390}, "words": "轻度至中度肾功能不全者的药物剂量无需.非布可他的推存起始别量为40m"}, {"probability": {"variance": 0.027462, "average": 0.919589, "min": 0.385129}, "location": {"width": 938, "top": 820, "height": 75, "left": 344}, "words": "每口一次服用2周后血清尿酸达到6mgd以下者,推荐用80mg度肾功能不全"}, {"probability": {"variance": 0.02673, "average": 0.89435, "min": 0.544671}, "location": {"width": 292, "top": 861, "height": 50, "left": 344}, "words": "数据不充分。请慎用"}, {"probability": {"variance": 0.02822, "average": 0.900867, "min": 0.361287}, "location": {"width": 641, "top": 906, "height": 59, "left": 388}, "words": "非布司他在肾功能损害末期需要进行透析的者中未进行听究"}, {"probability": {"variance": 0.020725, "average": 0.899332, "min": 0.489011}, "location": {"width": 897, "top": 948, "height": 68, "left": 383}, "words": "肝功能不全:轻度( Child. Pugh A)或者中( chi'd-pugh B级)肝功能不全者,相"}, {"probability": {"variance": 0.028093, "average": 0.870892, "min": 0.353649}, "location": {"width": 938, "top": 986, "height": 70, "left": 340}, "words": "对正常肝功能者,多次服用80mg的非布他,Cx与ACu(总量与离态)平均增加"}, {"probability": {"variance": 0.037321, "average": 0.841586, "min": 0.430719}, "location": {"width": 852, "top": 1028, "height": 75, "left": 427}, "words": "103,不同的塑划中,血清尿酸浓度下降率类似(健康组62%,轻开功能不全"}, {"probability": {"variance": 0.048357, "average": 0.741524, "min": 0.389608}, "location": {"width": 187, "top": 1069, "height": 43, "left": 374}, "words": "19%中攻能"}, {"probability": {"variance": 0.061312, "average": 0.824802, "min": 0.417383}, "location": {"width": 217, "top": 1107, "height": 45, "left": 333}, "words": "对重度能害"}, {"probability": {"variance": 0.047272, "average": 0.849098, "min": 0.376979}, "location": {"width": 614, "top": 1082, "height": 57, "left": 662}, "words": "%)。度与中度肝功能不全者的药物剂无需周,尚"}, {"probability": {"variance": 0.02558, "average": 0.861784, "min": 0.55867}, "location": {"width": 461, "top": 1123, "height": 47, "left": 635}, "words": " Pugh C级)进行研究,此类思者应进慎使用"}, {"probability": {"variance": 0.057068, "average": 0.746645, "min": 0.491034}, "location": {"width": 91, "top": 1194, "height": 29, "left": 333}, "words": "14%然"}, {"probability": {"variance": 0.025827, "average": 0.92776, "min": 0.362891}, "location": {"width": 646, "top": 1162, "height": 59, "left": 628}, "words": "化,女性比男性的非布他Cm和ALC分别高出30%和"}, {"probability": {"variance": 0.047792, "average": 0.821299, "min": 0.362366}, "location": {"width": 701, "top": 1201, "height": 61, "left": 568}, "words": "后C与AUC在性别中相似,此外,性划问的血尿酸度"}, {"probability": {"variance": 0.029875, "average": 0.901816, "min": 0.454976}, "location": {"width": 502, "top": 1231, "height": 59, "left": 333}, "words": "下降率也无需根据性别进行药物剂盘调整"}, {"probability": {"variance": 0.016197, "average": 0.940858, "min": 0.460748}, "location": {"width": 532, "top": 1277, "height": 57, "left": 374}, "words": "种族:尚对不同种族进行特殊药代动力学的研究"}, {"probability": {"variance": 0.032405, "average": 0.904095, "min": 0.504935}, "location": {"width": 153, "top": 1320, "height": 34, "left": 372}, "words": "药物相草作用"}, {"probability": {"variance": 0.003097, "average": 0.965124, "min": 0.82397}, "location": {"width": 296, "top": 1361, "height": 43, "left": 372}, "words": "非布可他时其它药物的影响"}, {"probability": {"variance": 0.028426, "average": 0.86031, "min": 0.377825}, "location": {"width": 897, "top": 1402, "height": 68, "left": 367}, "words": "黄嘌吟罕化酶底物类药物硫嘌呤、嗓和杀:非布可是一个黄嘌吟氧化酶帅"}, {"probability": {"variance": 0.018165, "average": 0.931518, "min": 0.388252}, "location": {"width": 916, "top": 1443, "height": 66, "left": 322}, "words": "制剂一项以健康受试者为试验对、在评估本品对茶能药代动力学影响的试验表明"}, {"probability": {"variance": 0.024621, "average": 0.902814, "min": 0.483709}, "location": {"width": 918, "top": 1480, "height": 73, "left": 322}, "words": "本品与茶碱同对服将导型尿中茶碱的主要代谢物之一1甲基黄吟的含量增大400倍"}, {"probability": {"variance": 0.023492, "average": 0.886084, "min": 0.498318}, "location": {"width": 934, "top": 1523, "height": 73, "left": 324}, "words": "白干人体长期杂露于1甲黄呤的安全性尚不明确,非布司他与茶同时给药时应谨"}, {"probability": {"variance": 0.053072, "average": 0.846245, "min": 0.358124}, "location": {"width": 870, "top": 1610, "height": 66, "left": 360}, "words": "本品与通过黄嘌氧化代谢的药物如唑嘌呤》的相互作用进行研究"}, {"probability": {"variance": 0.02465, "average": 0.885212, "min": 0.437025}, "location": {"width": 943, "top": 1647, "height": 73, "left": 312}, "words": "本品对剪噪吟氧化的迎制可能会导致这些药物浆浓度升高,建而产生毒性,本品禁用"}, {"probability": {"variance": 0.027594, "average": 0.877615, "min": 0.480017}, "location": {"width": 678, "top": 1690, "height": 61, "left": 315}, "words": "于正在接受唑岭,味吟治疗的忠者[见禁忌和药物相互作用"}, {"probability": {"variance": 0.030318, "average": 0.887905, "min": 0.41003}, "location": {"width": 872, "top": 1736, "height": 63, "left": 358}, "words": "硫唑嘌和巯呤通过三个主要化谢途径进行代谢,其中一个黄呤氧化商介导"}, {"probability": {"variance": 0.030707, "average": 0.86997, "min": 0.402155}, "location": {"width": 936, "top": 1775, "height": 68, "left": 312}, "words": "虽末进行本品与硫唑哪呤和茨嘌呤药询相工作用的研究,但是噤呤(一个哪氧化"}, {"probability": {"variance": 0.028706, "average": 0.861858, "min": 0.442374}, "location": {"width": 934, "top": 1816, "height": 68, "left": 312}, "words": "酶抑制剂与唑嘌呤或流呤同时给药已发现这些药物内药浓度有显著升高:因为大品是"}, {"probability": {"variance": 0.035505, "average": 0.875883, "min": 0.373727}, "location": {"width": 938, "top": 1857, "height": 68, "left": 310}, "words": "一个吟氧化酶抑制剂,所以它可以抑制硫和筑呤由黄嘌呤氧化酶介导的代"}, {"probability": {"variance": 0.047928, "average": 0.809823, "min": 0.394925}, "location": {"width": 648, "top": 1898, "height": 59, "left": 306}, "words": "谢,导致瓷唑嘌呤疏呤血浓度升离,可能导致严重毒性"}, {"probability": {"variance": 0.022062, "average": 0.924236, "min": 0.379793}, "location": {"width": 868, "top": 1944, "height": 63, "left": 351}, "words": "P50底物药物:体外研究表明非司临床相关浓时不会抑制P450 CYPLA2"}], "language": 3}